Lotus Pharms Inc (LTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2017 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | N/A | 1,340 |
| Receivables | N/A | N/A | N/A | N/A | 1,970 |
| Inventories | N/A | N/A | N/A | N/A | 630 |
| Other current assets | 0 | 0 | 0 | 0 | 600 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $4,540 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 39,330 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 59,290 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $98,620 |
| Total Assets | $N/A | $N/A | $N/A | $N/A | $103,180 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 30 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 2,020 |
| Other current liabilities | N/A | N/A | N/A | N/A | 5,980 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $8,050 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 5,240 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 860 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $6,100 |
| Total Liabilities | $N/A | $N/A | $N/A | $N/A | $14,160 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | N/A | 20 |
| Retained earnings | N/A | N/A | N/A | N/A | 60,160 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 7,170 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $89,020 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $103,180 |